The potential relevance of the NKG2C–HLA-E axis in the context of SARS-CoV-2 infection is highlighted by a recent study showing an increased prevalence of the allelic variant NKG2Cdel, associated with a reduced NKG2C expression, among severe COVID-19 patients, compared with the healthy population (47). The gene discussed is HLA-E; the disease is COVID-19.